These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 37491929

  • 1. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S, Kadour E, Khoudja R, Ton-Leclerc S, Beauchamp C, Beltempo M, Dahan MH, Gold P, Jacques Kadoch I, Jamal W, Laskin C, Mahutte N, Reinblatt SL, Sylvestre C, Buckett W, Genest G.
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [Abstract] [Full Text] [Related]

  • 2. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T, Carp H, Shoenfeld Y.
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss.
    Kim JH, Kim SH, Yang N, Ko Y, Lee SR, Chae HD.
    J Korean Med Sci; 2022 Jun 27; 37(25):e200. PubMed ID: 35762143
    [Abstract] [Full Text] [Related]

  • 4. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
    Egerup P, Kolte AM, Larsen EC, Krog M, Nielsen HS, Christiansen OB.
    Hum Reprod; 2016 Nov 27; 31(11):2428-2434. PubMed ID: 27591241
    [Abstract] [Full Text] [Related]

  • 5. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
    Sung N, Khan SA, Yiu ME, Jubiz G, Salazar MD, Skariah A, Dambaeva S, Kwak-Kim J.
    J Reprod Immunol; 2021 Nov 27; 148():103369. PubMed ID: 34492567
    [Abstract] [Full Text] [Related]

  • 6. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
    Yang X, Meng T.
    J Immunol Res; 2020 Nov 27; 2020():6672865. PubMed ID: 33426092
    [Abstract] [Full Text] [Related]

  • 7. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
    Sato T, Sugiura-Ogasawara M, Ozawa F, Yamamoto T, Kato T, Kurahashi H, Kuroda T, Aoyama N, Kato K, Kobayashi R, Fukuda A, Utsunomiya T, Kuwahara A, Saito H, Takeshita T, Irahara M.
    Hum Reprod; 2019 Dec 01; 34(12):2340-2348. PubMed ID: 31811307
    [Abstract] [Full Text] [Related]

  • 8. Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes.
    Peero EK, Banjar S, Khoudja R, Ton-Leclerc S, Beauchamp C, Benoit J, Beltempo M, Dahan MH, Gold P, Kadoch IJ, Jamal W, Laskin C, Mahutte N, Phillips S, Sylvestre C, Reinblatt S, Mazer BD, Buckett W, Genest G.
    Sci Rep; 2024 Feb 16; 14(1):3876. PubMed ID: 38365988
    [Abstract] [Full Text] [Related]

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 10. Hydroxychloroquine in recurrent pregnancy loss: data from a French prospective multicenter registry.
    Dernoncourt A, Hedhli K, Abisror N, Cheloufi M, Cohen J, Kolanska K, McAvoy C, Selleret L, Ballot E, Mathieu d'Argent E, Chabbert Buffet N, Fain O, Kayem G, Mekinian A.
    Hum Reprod; 2024 Sep 01; 39(9):1934-1941. PubMed ID: 38942601
    [Abstract] [Full Text] [Related]

  • 11. Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
    Nørgaard-Pedersen C, Nielsen K, Steffensen R, Eriksen L, Jørgensen MM, Kesmodel US, Christiansen OB.
    BMJ Open; 2022 Sep 22; 12(9):e064780. PubMed ID: 36137638
    [Abstract] [Full Text] [Related]

  • 12. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.
    Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, Liao C.
    Hum Reprod; 2010 Sep 22; 25(9):2203-9. PubMed ID: 20634190
    [Abstract] [Full Text] [Related]

  • 13. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial.
    Yamada H, Deguchi M, Saito S, Takeshita T, Mitsui M, Saito T, Nagamatsu T, Takakuwa K, Nakatsuka M, Yoneda S, Egashira K, Tachibana M, Matsubara K, Honda R, Fukui A, Tanaka K, Sengoku K, Endo T, Yata H.
    EClinicalMedicine; 2022 Aug 22; 50():101527. PubMed ID: 35795714
    [Abstract] [Full Text] [Related]

  • 14. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D, Capalbo A, Dovere L, Tacconi L, Soscia D, Giancani A, Scepi E, Maggiulli R, Vaiarelli A, Rienzi L, Ubaldi FM.
    Hum Reprod; 2021 Mar 18; 36(4):929-940. PubMed ID: 33608730
    [Abstract] [Full Text] [Related]

  • 15. Anti-Müllerian hormone and live birth in unexplained recurrent pregnancy loss.
    Bliddal S, Feldt-Rasmussen U, Forman JL, Hilsted LM, Larsen EC, Christiansen OB, Nielsen CH, Kolte AM, Nielsen HS.
    Reprod Biomed Online; 2023 Jun 18; 46(6):995-1003. PubMed ID: 37055255
    [Abstract] [Full Text] [Related]

  • 16. Prevalence, causes, and impact of non-visualized pregnancy losses in a recurrent pregnancy loss population.
    Bedaiwy MA, Fayek B, Yang EC, Iews MS, Elgendi M, Abdelkareem AO, Abdellah AH, Liu YD, Jones A, Mayer U, Abdel Hafez FF.
    Hum Reprod; 2023 May 02; 38(5):830-839. PubMed ID: 36881694
    [Abstract] [Full Text] [Related]

  • 17. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
    Lee SK, Kim JY, Han AR, Hur SE, Kim CJ, Kim TH, Cho BR, Han JW, Han SG, Na BJ, Kwak-Kim J.
    Am J Reprod Immunol; 2016 Jan 02; 75(1):59-68. PubMed ID: 26510488
    [Abstract] [Full Text] [Related]

  • 18. Evaluating the role of paternal factors in aetiology and prognosis of recurrent pregnancy loss: study protocol for a hospital-based multicentre case-control study and cohort study (REMI III project).
    du Fossé N, van der Hoorn ML, Eikmans M, Heidt S, le Cessie S, Mulders A, van Lith J, Lashley E.
    BMJ Open; 2019 Nov 14; 9(11):e033095. PubMed ID: 31727666
    [Abstract] [Full Text] [Related]

  • 19. The Endometrial Immune Profiling May Positively Affect the Management of Recurrent Pregnancy Loss.
    Cheloufi M, Kazhalawi A, Pinton A, Rahmati M, Chevrier L, Prat-Ellenberg L, Michel AS, Dray G, Mekinian A, Kayem G, Lédée N.
    Front Immunol; 2021 Nov 14; 12():656701. PubMed ID: 33841443
    [Abstract] [Full Text] [Related]

  • 20. External validation of a frequently used prediction model for ongoing pregnancy in couples with unexplained recurrent pregnancy loss.
    Youssef A, van der Hoorn MLP, Dongen M, Visser J, Bloemenkamp K, van Lith J, van Geloven N, Lashley EELO.
    Hum Reprod; 2022 Mar 01; 37(3):393-399. PubMed ID: 34875054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.